Discovery of Two Potential and Novel Toll-like Receptor 7 Antagonists via Molecular Docking, Molecular Dynamics Simulation and In Vitro Biological Evaluation
- 1Key Laboratory of New Animal Drug of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China
Abstract
Objective: Toll-like receptor 7 (TLR7) is an important pattern recognition receptor. It mainly participates in the recognition of single-stranded RNA and is closely related to various disease processes. In humans, the enormous potential of TLR7 antagonists in reducing inflammation and alleviating autoimmune damage has been identified. Similar effects have also been observed in livestock and poultry. Therefore, using porcine TLR7 as the target, we combined virtual screening with a heterologous reporter gene assay to identify potential ligands, aiming to provide a research basis for the development of immune modulators. Methods: The structure of porcine TLR7 was predicted through homology modeling, and molecular docking was performed for virtual screening of potential ligands. ADMET and toxicity properties of small molecules were predicted. Subsequently, a mouse TLR7 reporter cell was employed for in vitro detection of TLR7 activity and cytotoxicity. The interaction modes and molecular dynamics simulations between hit compounds and receptors were further analyzed. Results: The porcine TLR7 structure was predicted by homology modeling. According to the scoring ranking of molecular docking and of ADMET and toxicity prediction, fifty compounds with satisfactory pharmacokinetic properties and safety were screened and their inhibitory effects on R848-induced TLR7 activation were verified. Among them, two hit compounds with novel structures, HY02-35 and HY02-46, exhibited significant mouse TLR7 antagonistic activity. HY02-35, with a parent nucleus structure of 2-indolone, exhibited an inhibitory concentration range between 10.25 and 38.23 µM, with a median estimate of 14.73 µM. The core structure of HY02-46 is 1,4-dihydropyrano [2,3-c] pyrazole, and the IC50 falls between 21.92 and 36.00 µM, with a median estimate of 26.61 µM. The above-mentioned hit compounds had strong interactions with porcine TLR7, formed stable complexes with the receptor, and can significantly reduce the mRNA levels of IFN-β and TNF-α. Conclusions: In short, this study obtained two hit compounds with novel structures and moderate inhibitory activity in vitro. These hits provide a starting point for subsequent structural optimization and in vivo pharmacological studies in porcine subjects.
Related
- Brominated 1,4-dihydropyridine derivatives as potential insecticides against the cotton aphid (Aphis gossypii): synthesis, characterization, biological evaluation, and molecular docking studies.
- Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel 1,2,4-Triazole-Functionalized Benzene-Sulfonate Derivatives as Potential Enzyme Inhibitors and Cytotoxicity in HepG2 Cells.
- New thiazole/coumarin hybrids as EGFR inhibitors with potential VEGFR-2 inhibition (design, synthesis, biological evaluation, and dynamic stimulation).
- Integrating artificial intelligence and molecular simulation for peptide discovery: limitations, validation and decision-centered workflows
- PeptidomicsDB: a unified resource of endogenous peptidomes for peptide discovery and functional exploration across species and biological contexts
BibTeX
@article{liu2026discovery,
title = {{Discovery of Two Potential and Novel Toll-like Receptor 7 Antagonists via Molecular Docking, Molecular Dynamics Simulation and In Vitro Biological Evaluation}},
author = {Chang Liu and Zhe Qin and Lixia Bai and Xiao Xu and Wenbo Ge and Zhun Li and Jianyong Li},
journal = {Molecules},
year = {2026},
month = oct,
doi = {10.3390/molecules31213903},
url = {https://www.mdpi.com/1420-3049/31/21/3903},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Discovery of Two Potential and Novel Toll-like Receptor 7 Antagonists via Molecular Docking, Molecular Dynamics Simulation and In Vitro Biological Evaluation
AU - Chang Liu
AU - Zhe Qin
AU - Lixia Bai
AU - Xiao Xu
AU - Wenbo Ge
AU - Zhun Li
AU - Jianyong Li
PY - 2026
DA - 2026/10/29
JO - Molecules
DO - 10.3390/molecules31213903
UR - https://www.mdpi.com/1420-3049/31/21/3903
AB - Objective: Toll-like receptor 7 (TLR7) is an important pattern recognition receptor. It mainly participates in the recognition of single-stranded RNA and is closely related to various disease processes. In humans, the enormous potential of TLR7 antagonists in reducing inflammation and alleviating autoimmune damage has been identified. Similar effects have also been observed in livestock and poultry. Therefore, using porcine TLR7 as the target, we combined virtual screening with a heterologous reporter gene assay to identify potential ligands, aiming to provide a research basis for the development of immune modulators. Methods: The structure of porcine TLR7 was predicted through homology modeling, and molecular docking was performed for virtual screening of potential ligands. ADMET and toxicity properties of small molecules were predicted. Subsequently, a mouse TLR7 reporter cell was employed for in vitro detection of TLR7 activity and cytotoxicity. The interaction modes and molecular dynamics simulations between hit compounds and receptors were further analyzed. Results: The porcine TLR7 structure was predicted by homology modeling. According to the scoring ranking of molecular docking and of ADMET and toxicity prediction, fifty compounds with satisfactory pharmacokinetic properties and safety were screened and their inhibitory effects on R848-induced TLR7 activation were verified. Among them, two hit compounds with novel structures, HY02-35 and HY02-46, exhibited significant mouse TLR7 antagonistic activity. HY02-35, with a parent nucleus structure of 2-indolone, exhibited an inhibitory concentration range between 10.25 and 38.23 µM, with a median estimate of 14.73 µM. The core structure of HY02-46 is 1,4-dihydropyrano [2,3-c] pyrazole, and the IC50 falls between 21.92 and 36.00 µM, with a median estimate of 26.61 µM. The above-mentioned hit compounds had strong interactions with porcine TLR7, formed stable complexes with the receptor, and can significantly reduce the mRNA levels of IFN-β and TNF-α. Conclusions: In short, this study obtained two hit compounds with novel structures and moderate inhibitory activity in vitro. These hits provide a starting point for subsequent structural optimization and in vivo pharmacological studies in porcine subjects.
SN - 1420-3049
ER -